Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Antrodia salmonea** is a medicinal fungus indigenous to Taiwan, traditionally used in folk medicine. It is known for its potential anticancer, anti-inflammatory, and antihypertensive activities. Bioactive compounds in Antrodia salmonea include triterpenoids and antrocins, which contribute to its pharmacological effects. Mechanistically, it induces apoptosis in various cancer cell lines, including colon and prostate cancer, through increased reactive oxygen species (ROS), activation of caspase pathways (notably caspase-3), PARP cleavage, cell cycle arrest, and regulation of p53 and androgen receptor signaling. It also demonstrates notable anti-inflammatory activity and potential inhibition of angiotensin-converting enzyme 2 (ACE2), suggesting utility in viral entry inhibition. The extract is used in complementary and alternative medicine for various conditions, such as diarrhea, abdominal pain, hypertension, and potentially cancer[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on antrodia salmonea.